Evidence map›Paper›PMID 35788732›Full record

ArticleOncology nursing forum2022

Domains of Structured Oral Anticancer Medication Programs: A Scoping Review.

Kapeena Sivakumaran, Pamela K Ginex, Haya Waseem, Sarah M Belcher, Sarah Lagler-Clark, Kristine B LeFebvre, Nicole Palmer, Tejanth Pasumarthi, Rebecca L Morgan

Abstract readScoping Review
In one paragraph

Article in Oncology nursing forum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kapeena SivakumaranEvidence Foundation.
Pamela K GinexOncology Nursing Society.
Haya WaseemEvidence Foundation.
Sarah M BelcherUniversity of Pittsburgh.
Sarah Lagler-ClarkEvidence Foundation.
Kristine B LeFebvreOncology Nursing Society.
Nicole Palmer
Tejanth PasumarthiEvidence Foundation.
Rebecca L MorganMcMaster University.

Funding

Understanding Oral Anticancer Medication Adherence among Patients with Multiple MyelomaK23NR019296 · NINR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BELCHER, SARAH M. · 2020 to 2022
$368k
NINR NIH HHS K23 NR019296
6 · The paper itself

Abstract

problem identificationAn interprofessional approach is necessary to support the multifactorial process of patient adherence to oral anticancer medications (OAMs). This scoping review aims to identify structured OAM programs in published literature, identify components within studies, and propose a framework for institutions developing or maintaining OAM programs. LITERATURE SEARCH: Embase®, PubMed®, and CINAHL® databases were searched for studies published between January 2000 and April 2021. DATA EVALUATION: Two reviewers screened studies and extracted data. Characteristics and specific domains of the OAM programs were captured. Key components of the programs were identified, and a framework was created to guide program development. SYNTHESIS: Components identified among the 21 studies were education; counseling; follow-up; dedicated clinician contact; adverse event and toxicity monitoring; adherence monitoring; drug procurement, delivery, and supply; patient- and system-level cost reduction; information technology; and risk assessment. IMPLICATIONS FOR RESEARCH: Based on the findings, a framework for building and evaluating OAM adherence programs is proposed. Future studies should evaluate the reliability and validity of this framework because further testing may lead to the development of additional components.

Indexed as

Antineoplastic AgentsHumansPatient ComplianceReproducibility of ResultsAntineoplastic Agentsmedication adherencenursingoncology careoral anticancer medicationscoping review

Identifiers

PMID35788732
PMCPMC9303043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.